𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas

✍ Scribed by Vivien H. C. Bramwell; H. T. Mouridsen; A. Santoro; G. Blackledge; R. Somers; D. Thomas; R. Sylvester; Allan Van Oosterom

Publisher
Springer
Year
1986
Tongue
English
Weight
442 KB
Volume
18
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II study of ifosfamide/mesna wit
A phase II study of ifosfamide/mesna with doxorubicin for adult soft tissue sarcoma
✍ Brian M. J. Cantwell; James Carmichael; Sarah Ghani; Adrian L. Harris πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 418 KB

In a phase II study, 16 adult patients with locally advanced or metastatic soft tissue sarcomas were treated with i.v. infusions of ifosfamide/mesna 5 g/m2 plus i.v. doxorubicin 40 mg/m2. Courses were given every 3 weeks up to a maximum of six courses in responding patients. Six patients (37.5%) had

Phase II trial of echinomycin in advance
Phase II trial of echinomycin in advanced soft tissue sarcomas
✍ Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 232 KB

Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin

A phase II trial of temozolomide in pati
A phase II trial of temozolomide in patients with unresectable or metastatic soft tissue sarcoma
✍ Susan M. Talbot; Mary Louise Keohan; Mary Hesdorffer; Russell Orrico; Emilia Bag πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 69 KB πŸ‘ 3 views

## Abstract ## BACKGROUND The objective of this study was to assess the efficacy and toxicity of the imidazotetrazine derivative temozolomide for patients with unresectable or metastatic soft tissue sarcoma. ## METHODS Twenty‐five of 26 patients were eligible and assessable for toxicity and resp